Welcome to the Pacific Edge Investor Centre. Here you will find useful information about being a shareholder of our company.
See the latest news and presentations, keep up to date with our newsletters and shareholder reports, find out when we are holding shareholder meetings and check up on our share price.
Pacific Edge is a publicy listed company on the NZX: listed as PEB.
- Value $00,000.000
- Volume 00,000
- Capitalisation $000,000
- Open $0.000
- Close $0.000
- High $0.000
- Low $0.000
Data up to date as of 00-00-0000 00:00
Pacific Edge Reports Growth & Continued Progress in FY20
We're pleased to announce the release of our audited financial results for the 12 months ended 31 March 2020 (FY20). The results report continued growth and progress towards our commercial goals, with increased adoption and use of Cxbladder alongside substantial updates to our supporting base of peer reviewed publications. [read more]
Renowned US Oncologist & Author Recommends Cxbladder
Renowned Oncologist and Author Dr Mark Scholz discusses the benefits of Cxbladder as a substitute for cystoscopy during an interview on Prostate Cancer and the implications of blood in urine. [read more]
New Webinar: Alternative Strategies to Deliver Bladder Cancer Investigation During COVID-19 and Beyond
In a discussion led by Neal Shore, MD, on the high profile UroToday platform, two influential urologists discuss their use of Cxbladder’s In-Home Sampling Programme and how it is currently being used by different urologists around the US to streamline patient care. [read more]
Reports and Presentations
For further investor information on Pacific Edge our recent annual reports, investor presentations and investment research reports are available for download below